Solidion Technology, Inc. Provides Drop-in Solutions to the Production of Solid-State Batteries
February 20, 2024 09:00 ET
|
Solidion Technology, Inc.
Solidion’s disruptive approach to production of Solid-state batteries.
Solidion Technology Inc. Ready to Produce Sustainable Graphite Anode Materials, a Key Component in Lithium-ion Batteries
February 15, 2024 16:30 ET
|
Solidion Technology, Inc.
Solidion Technology Inc. Ready to Produce Sustainable Graphite Anode Materials, a Key Component in Lithium-ion Batteries
EAGLE PHARMACEUTICALS 48 HOUR DEADLINE ALERT: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options
February 08, 2024 11:00 ET
|
Faruqi & Faruqi LLP
If you suffered losses exceeding $100,000 investing in Eagle Pharmaceuticals stock or options between August 8, 2023 and November 28, 2023 and would like to discuss your legal rights, call Faruqi...
EAGLE PHARMACEUTICALS INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options
February 01, 2024 17:30 ET
|
Faruqi & Faruqi LLP
If you suffered losses exceeding $100,000 investing in Eagle Pharmaceuticals stock or options between August 8, 2023 and November 28, 2023 and would like to discuss your legal rights, call Faruqi...
EAGLE PHARMACEUTICALS SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options
January 24, 2024 09:45 ET
|
Faruqi & Faruqi LLP
If you suffered losses exceeding $100,000 investing in Eagle Pharmaceuticals stock or options between August 8, 2023 and November 28, 2023 and would like to discuss your legal rights, call Faruqi...
EAGLE PHARMACEUTICALS SHAREHOLDER NOTICE: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Eagle Pharmaceuticals To Contact Him Directly To Discuss Their Options
January 10, 2024 10:00 ET
|
Faruqi & Faruqi LLP
If you suffered losses exceeding $100,000 investing in Eagle Pharmaceuticals stock or options between August 8, 2023 and November 28, 2023 and would like to discuss your legal rights, call Faruqi...
Eagle Pharmaceuticals Investor Update: Kaplan Fox & Kilsheimer LLP Notifies Eagle Pharmaceuticals Investors of a Class Action and Upcoming Deadline
December 13, 2023 12:30 ET
|
Kaplan Fox & Kilsheimer LLP
Kaplan Fox notifies investors of Class Action filed against Eagle Pharmaceuticals.
Titan Reports Record Production Results for Third Quarter 2023
November 14, 2023 18:20 ET
|
Titan Mining Corporation
VANCOUVER, British Columbia, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Titan Mining Corporation (TSX: TI) (“Titan” or the "Company") announces the results for the quarter ended September 30, 2023. (All...
Synthetic Graphite Market Surges Ahead with a Projected Value of $4.16 Billion by 2028: Key Drivers and Trends Unveiled
November 08, 2023 04:43 ET
|
Research and Markets
Dublin, Nov. 08, 2023 (GLOBE NEWSWIRE) -- The "Synthetic Graphite Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)" report has been added to ResearchAndMarkets.com's...
Titan Mining Advances Kilbourne Exploration, With Surface Trenching and Bulk Sample Identification Underway
November 02, 2023 06:00 ET
|
Titan Mining Corporation
VANCOUVER, British Columbia, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Titan Mining Corporation (TSX:TI) (“Titan” or the “Company”) is pleased to announce that it is advancing surface exploration activities...